PURPOSE: Obsessive compulsive disorder (OCD) is a debilitating mental disorder that often takes a chronic course. One of the factors influencing the treatment effectiveness in anxiety and depressive disorders is the self-stigma. This study focused on the relationship between the self-stigma, symptomatology, and therapeutic outcomes in patients with OCD. PATIENTS AND METHODS: Ninety-four inpatients with OCD, who did not sufficiently respond to at least one selective serotonin reuptake inhibitor trial, participated in the study. They attended a six-week therapeutic program consisting of exposure and response prevention, transdiagnostic group cognitive behavioral therapy, individual sessions, mental imagery, relaxation, sport, and ergotherapy. The participants completed several scales: the Internalized Stigma of Mental Illness Scale (ISMI), the self-report Yale-Brown Obsessive Compulsive Scale (Y-BOCS-SR), Beck Anxiety Scale (BAI), Beck Depression Scale-II (BDI-II), and Dissociative Experiences Scale (DES). A senior psychiatrist filled in the Clinical Global Impression (CGI-S). RESULTS: The average scales' scores considerably declined in all measurements except for DES. The self-stigma positively correlated with all psychopathology scales. It was also higher in patients with a comorbid personality disorder (PD). The higher self-stigma predicted a lower change in compulsion, anxiety, and depressive symptoms but not the change of obsessions or the overall psychopathology. CONCLUSION: The self-stigma presents an important factor connected to higher severity of OCD. It is also a minor predictor of a lower change in symptomatology after combined treatment.

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University in Olomouc University Hospital in Olomouc Olomouc The Czech Republic

Department of Psychiatry Hospital Liberec Prague The Czech Republic

Department of Psychology Sciences Faculty of Social Science and Health Care Constantine the Philosopher University in Nitra Nitra The Slovak Republic

Institute for Postgraduate Education in Health Care Prague The Czech Republic

See more in PubMed

Huppert JD, Simpson HB, Nissenson KJ, Liebowitz MR, Foa EB. Quality of life and functional impairment in obsessive-compulsive disorder: A comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depress Anxiety. 2009;26(1):39–45. doi:10.1002/da.20506 PubMed DOI PMC

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Ed.). Arlington, VA: Author; 2013.

Weingarden H, Renshaw KD. Shame in the obsessive compulsive related disorders: a conceptual review. J Affect Disord. 2015;171:74–84. doi:10.1016/j.jad.2014.09.010 PubMed DOI PMC

Basile B, Mancini F, Macaluso E, Caltagirone C, Bozzali M. Abnormal processing of deontological guilt in obsessive–compulsive disorder. Brain Struct Funct. 2014;219(4):1321–1331. doi:10.1007/s00429-013-0570-2 PubMed DOI

Williams MT, Farris SG, Turkheimer E, et al. Myth of the pure obsessional type in obsessive-compulsive disorder. Depress Anxiety. 2011;28(6):495–500. doi:10.1002/da.20820 PubMed DOI PMC

Prasko J, Raszka M, Adamcova K, et al. Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder.. Neuro Endocrinol Lett. 2009;30(5):615–623. PubMed

Torres AR, Prince MJ. A importância de estudos epidemiológicos sobre o transtorno obsessivo-compulsivo. Rev Brasileira De Psiquiatria. 2004;26(3):141–142. doi:10.1590/s1516-44462004000300001 PubMed DOI

Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(2):269–276. doi:10.4088/jcp.v67n0214 PubMed DOI

Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive–compulsive disorder. Int J Neuropsychopharmacology. 2005;8(1):107–129. doi:10.1017/S1461145704004675 PubMed DOI

Öst L-G, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive–compulsive disorder. A systematic review and meta-analysis of studies published 1993–2014. Clin Psychol Rev. 2015;40:156–169. doi:10.1016/j.cpr.2015.06.003 PubMed DOI

Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D. International Treatment Refractory OCD Consortium. Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacology. 2002;5(2):181–191. doi:10.1017/S1461145702002900 PubMed DOI

Eisen JL, Sibrava NJ, Boisseau CL, et al. Five-year course of obsessive-compulsive disorder: predictors of remission and relapse. J Clin Psychiatry. 2013;74(3):233–239. doi:10.4088/JCP.12m07657 PubMed DOI PMC

Jakubovski E, Diniz JB, Valerio C, et al. Clinical predictors of long-term outcome in obsessive-compulsive disorder. Depress Anxiety. 2013;30(8):763–772. doi:10.1002/da.22013 PubMed DOI

Semiz UB, Inanc L, Bezgin CH. Are trauma and dissociation related to treatment resistance in patients with obsessive–compulsive disorder? Soc Psychiatry Psychiatr Epidemiol. 2014;49(8):1287–1296. doi:10.1007/s00127-013-0787-7 PubMed DOI

Knopp J, Knowles S, Bee P, Lovell K, Bower P. A systematic review of predictors and moderators of response to psychological therapies in OCD: do we have enough empirical evidence to target treatment? Clin Psychol Rev. 2013;33(8):1067–1081. doi:10.1016/j.cpr.2013.08.008 PubMed DOI

Goffman E. Stigma: Notes on the Management of Spoiled Identity. New York: Touchstone; 1986.

Corrigan PW, Nieweglowski K, Sayer J. Self-stigma and the mediating impact of the “why try” effect on depression. J Community Psychol. 2019;47(3):698–705. doi:10.1002/jcop.22144 PubMed DOI

Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: A systematic review and meta-analysis. Soc Sci Med. 2010;71(12):2150–2161. doi:10.1016/j.socscimed.2010.09.030 PubMed DOI

Prasko J, Ociskova M, Grambal A, Sigmundova Z. Slepecky M. Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder. Neuropsychiatric Dis Treat. 2016;12:2539–2552. doi:10.2147/NDT.S117037 PubMed DOI PMC

Ansari E, Mishra S, Tripathi A, Kar SK, Dalal PK. Cross-sectional study of internalised stigma and medication adherence in patients with obsessive compulsive disorder. General Psychiatry. 2020;33(2):e100180. doi:10.1136/gpsych-2019-100180 PubMed DOI PMC

Grambal A, Prasko J, Kamaradova D, et al. Self-stigma in borderline personality disorder - Cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders. Neuropsychiatr Dis Treat. 2016;(2016(12):2439–2448. doi:10.2147/NDT.S114671 PubMed DOI PMC

Ociskova M, Prasko J, Kamaradova D, Grambal A, Sigmundova Z. Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities. Neuropsych Dis Treat. 2015;11:1767–1779. doi:10.2147/NDT.S87737 PubMed DOI PMC

Ociskova M, Prasko J, Vrbova K, Kasalova P, Holubova M. Self-stigma and treatment effectiveness in patients with anxiety disorders – a mediation analysis. Neuropsychiatric Dis Treat. 2018;14:383–392. doi:10.2147/NDT.S152208 PubMed DOI PMC

Deres AT, Bürkner P-C, Klauke B, Buhlmann U. The role of stigma during the course of inpatient psychotherapeutic treatment in a German sample. Clin Psychol Psychother. 2020;27(2):239–248. doi:10.1002/cpp.2423 PubMed DOI

Prasko J, Ociskova M, Latalova K, Kamaradova D, Grambal A. Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients. Neuropsychiatric Dis Treat. 2016;12:1539–1551. doi:10.2147/NDT.S104301 PubMed DOI PMC

Picco L, Lau YW, Pang S, et al. Mediating effects of self-stigma on the relationship between perceived stigma and psychosocial outcomes among psychiatric outpatients: findings from a cross-sectional survey in Singapore. BMJ Open. 2017;7(8):e018228. doi:10.1136/bmjopen-2017-018228 PubMed DOI PMC

Glazier K, Wetterneck C, Singh S, Williams M. Stigma and shame as barriers to treatment for obsessive-compulsive and related disorders. J Depression Anxiety. 2015;4(3):191. doi:10.4191/2167-1044.1000191 DOI

Stengler-Wenzke K, Trosbach J, Dietrich S, Angermeyer MC. Experience of stigmatization by relatives of patients with obsessive compulsive disorder. Arch Psychiatr Nurs. 2004;18(3):88–96. doi:10.1016/j.apnu.2004.03.004 PubMed DOI

World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: Author; 1992.

Storch EA, De Nadai AS, Conceição Do Rosário M. Defining clinical severity in adults with obsessive–compulsive disorder. Compr Psychiatry. 2015;63:30–35. doi:10.1016/j.comppsych.2015.08.007 PubMed DOI PMC

Julian LJ. Measures of anxiety: state-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63(S11):S467–S472. doi:10.1002/acr.20561 PubMed DOI PMC

Ociskova M, Prasko J, Kamarádová D, et al. Self-stigma in psychiatric patients--standardization of the ISMI scale.. Neuro Endocrinol Lett. 2014;35(7):624–632. PubMed

Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121(1):31–49. doi:10.1016/j.psychres.2003.08.008 PubMed DOI

Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville: DHEW; 1976.

Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003;33(4):611–622. doi:10.1017/s0033291703007414 PubMed DOI

Goodman WK. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–1011. doi:10.1001/archpsyc.1989.01810110048007 PubMed DOI

Baer L, Brown-Beasley MW, Sorce J, Henriques AI. Computer-assisted telephone administration of a structured interview for obsessive-compulsive disorder. Am J Psychiatry. 1993;150(11):1737–1738. doi:10.1176/ajp.150.11.1737 PubMed DOI

Rapp AM, Bergman RL, Piacentini J, McGuire J. Evidence-Based Assessment of Obsessive–Compulsive Disorder. J Cent Nerv Syst Dis. 2016;8:13–29. doi:10.4137/JCNSD.S38359 PubMed DOI PMC

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties.. J Consult Clin Psychol. 1988;56(6):893–897. doi:10.1037/0022-006X.56.6.893 PubMed DOI

Kamaradova D, Prasko J, Latalova K, et al. Psychometric properties of the Czech version of the Beck Anxiety Inventory - comparison between diagnostic groups.. Neuro Endocrinol Lett. 2015;36(7):706–712. PubMed

Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatients. J Pers Assess. 1996;67(3):588–597. doi:10.1207/s15327752jpa6703_13 PubMed DOI

Ociskova M, Prasko J, Kupka M, et al. Psychometric evaluation of the Czech Beck Depression Inventory-II in a sample of depressed patients and healthy controls.. Neuro Endocrinol Lett. 2017;38(2):98–106. PubMed

Carlson EB, Putnam FW. An update on the Dissociative Experience Scale: an update on the Dissociative. Dissociation. 1993;6:16–27. doi:10.1177/1073191116645904 DOI

Ptacek R, Bob P, Paclt I. Skala disociativnich zkusenosti – ceska verze [Dissociative Experiences Scale – A Czech Version]. Cesk Psychol. 2006;50(3):262–272.

Prasko J, Kamaradova D, Cakirpaloglu S, et al. Predicting the therapeutic response to intensive psychotherapeutic programs in patients with neurotic spectrum disorders. Act Nervosa Superior Rediviva. 2015;57(1–2):30–39.

Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191. doi:10.3758/bf03193146 PubMed DOI

Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.

European Medicines Agency. Guideline for good clinical practice E6 (R2) (2018). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf. Accessed 3August 2020..

Lochner C, Stein DJ. Gender in obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Arch Women’s Mental Health. 2001;4(1):19–26. doi:10.1007/s007370170004 DOI

Brakoulias V, Starcevic V, Belloch A, et al. Comorbidity, age of onset and suicidality in obsessive–compulsive disorder (OCD): an international collaboration. Compr Psychiatry. 2017;76:79–86. doi:10.1016/j.comppsych.2017.04.002 PubMed DOI

Melca IA, Yücel M, Mendlowicz MV, de Oliveira-souza R, Fontenelle LF. The correlates of obsessive–compulsive, schizotypal, and borderline personality disorders in obsessive–compulsive disorder. J Anxiety Disord. 2015;33:15–24. doi:10.1016/j.janxdis.2015.04.004 PubMed DOI

Jónsson H, Hougaard E. Group cognitive behavioural therapy for obsessive-compulsive disorder: A systematic review and meta-analysis. Acta Psychiatr Scand. 2009;119(2):98–106. doi:10.1111/j.1600-0447.2008.01270.x PubMed DOI

Sunde T, Walseth LT, Himle JA, et al. A long-term follow-up of group behavioral therapy for obsessive-compulsive disorder in a general outpatient clinic in Norway. J Obsessive Compuls Relat Disord. 2017;14:59–64. doi:10.1016/j.jocrd.2017.06.002 DOI

Prasko J, Grambal A, Kasalova P, et al. Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders. Neuropsychiatric Dis Treat. 2016;12:2659–2676. doi:10.2147/NDT.S118058 PubMed DOI PMC

Tatlı M, Cetinkaya O, Maner F. Evaluation of relationship between obsessive-compulsive disorder and dissociative experiences. Clin Psychopharmacol Neurosci. 2018;16(2):161–167. doi:10.9758/cpn.2018.16.2.161 PubMed DOI PMC

Belli H. Dissociative symptoms and dissociative disorders comorbidity in obsessive compulsive disorder: symptom screening, diagnostic tools and reflections on treatment. World J Clin Cases. 2014;2(8):327–331. doi:10.12998/wjcc.v2.i8.327 PubMed DOI PMC

Taylor S, Cox BJ. An expanded Anxiety Sensitivity Index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord. 1998;12(5):463–483. doi:10.1016/s0887-6185(98)00028-0 PubMed DOI

Robinson LJ, Freeston MH. Emotion and internal experience in Obsessive Compulsive Disorder: reviewing the role of alexithymia, anxiety sensitivity and distress tolerance. Clin Psychol Rev. 2014;34(3):256–271. doi:10.1016/j.cpr.2014.03.003 PubMed DOI

Rüsch N, Lieb K, Göttler I, et al. Shame and implicit self-concept in women with borderline personality disorder. Am J Psychiatry. 2007;164(3):500–508. doi:10.1176/ajp.2007.164.3.500 PubMed DOI

Thiese MS, Ronna B, Ott U. P value interpretations and considerations. J Thorac Dis. 2016;8(9):E928–E931. doi:10.21037/jtd.2016.08.16 PubMed DOI PMC

Perez V, Barrachina J, Soler J, et al. The clinical global impression scale for borderline personality disorder patients (CGI-BPD): a scale sensible to detect changes.. Actas Esp Psiquiatr. 2007;35(4):229–235. PubMed

Alreja S, Sengar S, Singh A, Mishra D. Insight and its relationship with stigma in psychiatric patients. Industrial Psychiatry J. 2009;18(1):39–42. doi:10.4103/0972-6748.57858 PubMed DOI PMC

Lien Y-J, Chang H-A, Kao Y-C, Tzeng N-S, Lu C-W, Loh C-H. Insight, self-stigma and psychosocial outcomes in Schizophrenia: a structural equation modelling approach. Epidemiol Psychiatr Sci. 2018;27(2):176–185. doi:10.1017/S2045796016000950 PubMed DOI PMC